WCPO: Eyes are the focus of new University of Cincinnati study to treat PTSD

woman

Kate Chard, PhD, UC professor of psychiatry and behavioral neuroscience.

Eyes are the focus of a new study to help heal combat veterans of their post-traumatic stress tied to their service.

Kate Chard, PhD, UC professor of psychiatry and behavioral neuroscience and director of PTSD programs at the Cincinnati Department of Veterans Affairs Medical Center, spoke with WCPO about a study examining the effectiveness of Eye Movement Desensitization and Reprocessing to Cognitive Processing Therapy.

A $1.25 million donation from PESI, one of the world’s largest providers of mental health continuing education, is funding the three-year study. 

“This therapy allows you to think of all the things that you don't want to tell anyone, even your best combat friend, and it allows you to keep all of that private, and you can still get better and not have those memories control you in the future,” Chard said.

Watch the WCPO segment

Featured image at top: CARE/Crawley building. Photo/Chris Radcliffe for the UC Foundation

Next Now

With its focus on innovation and impact, Next, Now: The Campaign for Cincinnati is where ambition meets action. At the University of Cincinnati and UC Health, we’re driven by next; thinking bolder and dreaming bigger to create the tomorrow we envision, today. Learn more at nextnow.uc.edu.

Related Stories

7322 Results
1

Future of Nursing 2020-2030 report to be released

May 5, 2021

The Future of Nursing 2020-2030: “Charting a Path to Achieve Health Equity” is being released on Tuesday, May 11. Greer Glazer, PhD, dean of the University of Cincinnati College of Nursing is one of the 15 people who served on the committee composing the report. The report explores how nurses can work over the next decade to reduce health disparities and promote equity, while keeping costs at bay, utilizing technology and maintaining patient and family-focused care.

2

A new treatment for rare muscular disease

April 16, 2021

Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.